-
Something wrong with this record ?
The effect of light wavelength on in vitro bilirubin photodegradation and photoisomer production
HJ. Vreman, S. Kourula, J. Jašprová, L. Ludvíková, P. Klán, L. Muchová, L. Vítek, BK. Cline, RJ. Wong, DK. Stevenson,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1967 to 1 year ago
ProQuest Central
from 2016-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2016-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2016-01-01 to 1 year ago
- MeSH
- Bilirubin analogs & derivatives blood chemistry radiation effects MeSH
- Photolysis radiation effects MeSH
- Phototherapy methods MeSH
- Isomerism MeSH
- Humans MeSH
- Serum Albumin, Human chemistry radiation effects MeSH
- Infant, Newborn MeSH
- Hyperbilirubinemia, Neonatal blood therapy MeSH
- Spectrophotometry MeSH
- Light * MeSH
- In Vitro Techniques MeSH
- Check Tag
- Humans MeSH
- Infant, Newborn MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The action spectrum for bilirubin photodegradation has been intensively studied. However, questions still remain regarding which light wavelength most efficiently photodegrades bilirubin. In this study, we determined the in vitro effects of different irradiation wavelength ranges on bilirubin photodegradation. METHODS: In our in vitro method, normalized absolute irradiance levels of 4.2 × 1015 photons/cm2/s from light-emitting diodes (ranging from 390-530 nm) and 10-nm band-pass filters were used to irradiate bilirubin solutions (25 mg/dL in 4% human serum albumin). Bilirubin and its major photoisomer concentrations were determined; the half-life time of bilirubin (t1/2) was calculated for each wavelength range, and the spectral characteristics for bilirubin photodegradation products were obtained for key wavelengths. RESULTS: The in vitro photodegradation of bilirubin at 37 °C decreased linearly as the wavelength was increased from 390 to 500 nm with t1/2 decreasing from 63 to 17 min, respectively. At 460 ± 10 nm, a significantly lower rate of photodegradation and thus higher t1/2 (31 min) than that at 500 nm (17 min) was demonstrated. CONCLUSION: In our system, the optimum bilirubin photodegradation and lumirubin production rates occurred between 490 and 500 nm. Spectra shapes were remarkably similar, suggesting that lumirubin production was the major process of bilirubin photodegradation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20022765
- 003
- CZ-PrNML
- 005
- 20201214124754.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41390-019-0310-2 $2 doi
- 035 __
- $a (PubMed)30710116
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vreman, Hendrik J $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA. henk.vreman@stanford.edu.
- 245 14
- $a The effect of light wavelength on in vitro bilirubin photodegradation and photoisomer production / $c HJ. Vreman, S. Kourula, J. Jašprová, L. Ludvíková, P. Klán, L. Muchová, L. Vítek, BK. Cline, RJ. Wong, DK. Stevenson,
- 520 9_
- $a BACKGROUND: The action spectrum for bilirubin photodegradation has been intensively studied. However, questions still remain regarding which light wavelength most efficiently photodegrades bilirubin. In this study, we determined the in vitro effects of different irradiation wavelength ranges on bilirubin photodegradation. METHODS: In our in vitro method, normalized absolute irradiance levels of 4.2 × 1015 photons/cm2/s from light-emitting diodes (ranging from 390-530 nm) and 10-nm band-pass filters were used to irradiate bilirubin solutions (25 mg/dL in 4% human serum albumin). Bilirubin and its major photoisomer concentrations were determined; the half-life time of bilirubin (t1/2) was calculated for each wavelength range, and the spectral characteristics for bilirubin photodegradation products were obtained for key wavelengths. RESULTS: The in vitro photodegradation of bilirubin at 37 °C decreased linearly as the wavelength was increased from 390 to 500 nm with t1/2 decreasing from 63 to 17 min, respectively. At 460 ± 10 nm, a significantly lower rate of photodegradation and thus higher t1/2 (31 min) than that at 500 nm (17 min) was demonstrated. CONCLUSION: In our system, the optimum bilirubin photodegradation and lumirubin production rates occurred between 490 and 500 nm. Spectra shapes were remarkably similar, suggesting that lumirubin production was the major process of bilirubin photodegradation.
- 650 _2
- $a bilirubin $x analogy a deriváty $x krev $x chemie $x účinky záření $7 D001663
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenecká hyperbilirubinemie $x krev $x terapie $7 D051556
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a isomerie $7 D007536
- 650 12
- $a světlo $7 D008027
- 650 _2
- $a fotolýza $x účinky záření $7 D010782
- 650 _2
- $a fototerapie $x metody $7 D010789
- 650 _2
- $a lidský sérový albumin $x chemie $x účinky záření $7 D000075462
- 650 _2
- $a spektrofotometrie $7 D013053
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kourula, Stephanie $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
- 700 1_
- $a Jašprová, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Kateřinská 32, 120 00, Prague, Czech Republic.
- 700 1_
- $a Ludvíková, Lucie $u Department of Chemistry and RECETOX, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
- 700 1_
- $a Klán, Petr $u Department of Chemistry and RECETOX, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
- 700 1_
- $a Muchová, Lucie $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Kateřinská 32, 120 00, Prague, Czech Republic.
- 700 1_
- $a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Kateřinská 32, 120 00, Prague, Czech Republic. vitek@cesnet.cz.
- 700 1_
- $a Cline, Benjamin K $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
- 700 1_
- $a Wong, Ronald J $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
- 700 1_
- $a Stevenson, David K $u Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Room S214, Stanford, CA, 94305, USA.
- 773 0_
- $w MED00003741 $t Pediatric research $x 1530-0447 $g Roč. 85, č. 6 (2019), s. 865-873
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30710116 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214124754 $b ABA008
- 999 __
- $a ok $b bmc $g 1595084 $s 1113441
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 85 $c 6 $d 865-873 $e 20190126 $i 1530-0447 $m Pediatric research $n Pediatr Res $x MED00003741
- LZP __
- $a Pubmed-20201125